Abstract：【Objective】To study the effect of levodopa combined with rivastigmine on myotonia and dopa transporter in patients with Parkinson's disease (PD). 【Methods】 A total of 101 patients with early Parkinson disease treated in our hospital were randomly divided into control group (n=50) and observation group (n=51). Patients in the control group were treated with levodopa, and patients in the control group were treated with levodopa plus rivastigmine in continuous treatment for 6 months. Parkinson's severity, balance function, Parkinson's grade, clinical symptom improvement time, dopamine transporter radiation count and adverse reactions were compared between the two groups. 【Results】After treatment, UP-DRS (UP-DRS) in the observation group was lower than that in the control group (P<0.05); Berg balance score higher than that of the control group (P<0.05); Parkinson's Hoehn-Yahr classification was lower than that of the control group (P<0.05); Myotonic stiffness, resting tremor and bradykinesia were shorter than those in the control group (P<0.05). The ratio of basal ganglia (BG) to occipital lobe (OC) tended to increase, but the incidence of contralateral control group was higher than that before treatment (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group (P<0.05). 【Conclusion】 Levodopa combined with rivastigmine can alleviate the symptoms of PD, improve the balance ability of patients and reduce the adverse reactions in patients with Parkinson's disease.
朱冬梅, 熊学智. 左旋多巴联合卡巴拉汀治疗对帕金森病患者肌强直及多巴转运体的影响[J]. 医学临床研究, 2018, 35(5): 876-878.
ZHU Dong-mei, XIONG Xue-zhi. Effect of Levodopa Combined with Rivastigmine on Myotonia and Dopa Transporter in Patients with Parkinson's Disease. JOURNAL OF CLINICAL RESEARCH, 2018, 35(5): 876-878.
2018, Vol. 35 
